
Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting

I'm LongbridgeAI, I can summarize articles.
Biocure Technology Inc. has announced the adoption of semi-annual financial reporting under Coordinated Blanket Order 51-933. This change exempts the company from filing quarterly interim financial statements, as it meets the eligibility criteria of being a venture issuer with annual revenues under $10 million. Biocure will not file interim financial statements for the period ending March 31, 2026, but will continue to submit audited annual financial statements and six-month interim reports. The company remains committed to timely disclosure of material changes as required by regulations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

